Small molecules modulation of 14-3-3 protein-protein interactions

Drug Discovery Today: Technologies

Volumn 10, Issue 4, 2013, Pages

  Mori, Mattia ^a,c   Vignaroli, Giulia ^a   Botta, Maurizio ^a,b  

^a UNIVERSITY OF SIENA   (Italy)

^b Temple University   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIBASTATIN; FUSICOCCIN; IMATINIB; PHOSPHOSERINE; PROTEIN 14 3 3; PROTEIN INHIBITOR; PYRROLIDINONE; STABILIZING AGENT; UNCLASSIFIED DRUG;

ARTICLE; DEVELOPMENT; DRUG STRUCTURE; HUMAN; IC 50; LD 50; LIGAND BINDING; MARKET; MOLECULAR DOCKING; NEOPLASM; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

14-3-3 PROTEINS; DRUG DISCOVERY; HUMANS; PROTEIN CONFORMATION; PROTEIN INTERACTION MAPPING;

EID: 84886315105     PISSN: None     EISSN: 17406749     Source Type: Journal    
DOI: 10.1016/j.ddtec.2012.10.001     Document Type: Review

References (35)

1. D. Han Functional identification of a novel 14-3-3 epsilon splicing variant suggests dimerization is not necessary for 14-3-3 epsilon to inhibit UV-induced apoptosis Biochem. Biophys. Res. Commun. 396 2010 401 406
2. M. Takahashi Phosphopeptide-dependent labeling of 14-3-3 zeta proteins by fusicoccin-based fluorescent probes Angew. Chem. Int. Ed. Engl. 51 2012 509 512
3. N.N. Sluchanko, and N.B. Gusev Probable participation of 14-3-3 in tau protein oligomerization and aggregation J. Alzheimers Dis. 27 2011 467 476
4. B. Schumacher Structure of the p53 C-terminus bound to 14-3-3: implications for stabilization of the p53 tetramer FEBS Lett. 584 2010 1443 1448
5. G. Sadik Phosphorylation of tau at Ser214 mediates its interaction with 14-3-3 protein: implications for the mechanism of tau aggregation J. Neurochem. 1 2009 33 43
6. M. Mancini A new nonpeptidic inhibitor of 14-3-3 induces apoptotic cell death in chronic myeloid leukemia sensitive or resistant to imatinib J. Pharmacol. Exp. Ther. 336 2011 596 604
7. H. Daitoku Regulation of FoxO transcription factors by acetylation and protein-protein interactions Biochim. Biophys. Acta 1813 2011 1954 1960
8. P. Astuti, and B. Gabrielli Phosphorylation of Cdc25B3 Ser169 regulates 14-3-3 binding to Ser151 and Cdc25B activity Cell Cycle 10 2011 1960 1967
9. M.K. Petri PTPIP51, a positive modulator of the MAPK/Erk pathway, is upregulated in glioblastoma and interacts with 14-3-3beta and PTP1B in situ Histol. Histopathol. 26 2011 1531 1543
10. M. Molzan Structural insights of the MLF1/14-3-3 interaction FEBS J. 279 2012 563 571
11. A.K. Gardino Structural determinants of 14-3-3 binding specificities and regulation of subcellular localization of 14-3-3-ligand complexes: a comparison of the X-ray crystal structures of all human 14-3-3 isoforms Semin. Cancer Biol. 16 2006 173 182
12. C. Ottmann A structural rationale for selective stabilization of anti-tumor interactions of 14-3-3 proteins by cotylenin A J. Mol. Biol. 386 2009 913 919
13. C. Ottmann Phosphorylation-independent interaction between 14-3-3 and exoenzyme S: from structure to pathogenesis EMBO J. 26 2007 902 913
14. M. Molzan Impaired binding of 14-3-3 to C-RAF in Noonan syndrome suggests new approaches in diseases with increased Ras signaling Mol. Cell. Biol. 30 2010 4698 4711
15. X. Yang Structural basis for protein-protein interactions in the 14-3-3 protein family Proc. Natl. Acad. Sci. U. S. A. 103 2006 17237 17242
16. L. Zhang Raf-1 kinase and exoenzyme S interact with 14-3-3zeta through a common site involving lysine 49 J. Biol. Chem. 272 1997 13717 13724
17. L. Cortesi Identification of protein clusters predictive of response to chemotherapy in breast cancer patients J. Proteome Res. 8 2009 4916 4933
18. C.L. Neal, and D. Yu 14-3-3zeta as a prognostic marker and therapeutic target for cancer Expert Opin. Ther. Targets 14 2010 1343 1354
19. A. Matta 14-3-3zeta as novel molecular target for cancer therapy Expert Opin. Ther. Targets 16 2012 515 523
20. M.F. Leal Clinical implication of 14-3-3 epsilon expression in gastric cancer World J. Gastroenterol. 18 2012 1531 1537
21. Y. Liu The expression of seven 14-3-3 isoforms in human meningioma Brain Res. 1336 2010 98 102
22. D. Zang 14-3-3zeta Overexpression and abnormal beta-catenin expression are associated with poor differentiation and progression in stage I non-small cell lung cancer Clin. Exp. Med. 10 2010 221 228
23. X. Yang Targeting 14-3-3zeta in cancer therapy Cancer Gene Ther. 19 2012 153 159
24. W.H. Zhou Aberrant upregulation of 14-3-3o expression serves as an inferior prognostic biomarker for gastric cancer BMC Cancer 11 2011 397
25. Y. Matsui High sensitivity of an ELISA kit for detection of the gamma-isoform of 14-3-3 proteins: usefulness in laboratory diagnosis of human prion disease BMC Neurol. 11 2011 120
26. S.C. Masters, and H. Fu 14-3-3 proteins mediate an essential anti-apoptotic signal J. Biol. Chem. 276 2001 45193 45200
27. M. Mori Molecular dynamics and DFT study on HIV-1 nucleocapsid protein-7 in complex with viral genome J. Chem. Inf. Model. 50 2010 638 650
28. V. Corradi Identification of the first non-peptidic small molecule inhibitor of the c-Abl/14-3-3 protein-protein interactions able to drive sensitive and Imatinib-resistant leukemia cells to apoptosis Bioorg. Med. Chem. Lett. 20 2010 6133 6137
29. Botta, M. et al. (2011) Non peptidic 14-3-3 inhibitors and the use thereof. WO2011IB50640 20110216
30. V. Corradi Computational techniques are valuable tools for the discovery of protein-protein interaction inhibitors: the 14-3-3sigma case Bioorg. Med. Chem. Lett. 21 2011 6867 6871
31. H. Wu Microarray-assisted high-throughput identification of a cell-permeable small-molecule binder of 14-3-3 proteins Angew. Chem. Int. Ed. Engl. 49 2010 6528 6532
32. J. Zhao Discovery and structural characterization of a small molecule 14-3-3 protein-protein interaction inhibitor Proc. Natl. Acad. Sci. U. S. A. 108 2011 16212 16216
33. M. Wurtele Structural view of a fungal toxin acting on a 14-3-3 regulatory complex EMBO J. 22 2003 987 994
34. R. Rose Identification and structure of small-molecule stabilizers of 14-3-3 protein-protein interactions Angew. Chem. Int. Ed. Engl. 49 2010 4129 4132
35. A. Richter An optimised small-molecule stabiliser of the 14-3-3-PMA2 protein-protein interaction Chemistry 18 2012 6520 6527